Takeda inks co-promotion pact for Velcade in Japan
This article was originally published in Scrip
Executive Summary
Takeda has entered into an agreement to co-promote with Janssen Pharmaceutical (Johnson & Johnson) in Japan the multiple myeloma product Velcade (bortezomib).